IS-001 for Ureter Injury
Trial Summary
What is the purpose of this trial?
This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinator or your doctor for guidance.
Eligibility Criteria
This trial is for women aged 18-75 who are scheduled for robotic-assisted gynecological surgery using the da Vinci system with Firefly imaging. Participants must be able to consent.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single intravenous injection of IS-001 to aid in ureter visualization during robotic-assisted gynecological surgery
Follow-up
Participants are monitored for safety and effectiveness after the IS-001 injection and surgery
Treatment Details
Interventions
- IS-001 (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Intuitive Surgical
Lead Sponsor
Gary Guthart
Intuitive Surgical
Chief Executive Officer since 2010
PhD in Engineering, California Institute of Technology
Henry Charlton
Intuitive Surgical
Chief Medical Officer since 2023
MD from an unspecified institution